Novel Coronavirus: The Therapeutics

Prohost Letter #440
The Therapeutics
Gilead’s Remdesivir

Treating COVID-19 patients requires therapeutic products that can deal with moderate and severe persistent symptoms that are unwilling to ease or completely disappear after weeks of isolation, when following the distancing and wearing masks. The first product proven effective and safe to be granted FDA Emergency Use Approval (EUA) happens to be remdesivir from Gilead Sciences (This content is for paid subscribers.

Please click here to subscribe or here to log in.